Biovie (BIVI) Loans - Net (2018)
Biovie (BIVI) posted Loans - Net of -$250000.0 for Q2 2018.
Biovie (BIVI) Loans - Net (2018) Analysis & Trends
Biovie has reported Loans - Net for 1 years, with the latest figure at -$250000.0 in Q2 2018.
- Quarterly Loans - Net changed N/A year-over-year to -$250000.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was -$250000.0 (changed N/A YoY) and the FY2018 annual result came in at -$250000.0, changed N/A from the prior year.
- Loans - Net was little changed at -$250000.0 in Q2 2018 per BIVI's latest filing.
- Over five years, Loans - Net peaked at -$250000.0 in Q2 2018 and troughed at -$250000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Biovie | 13.91 Mn | 13.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -250,000.00 |
| Jun 30, 2018 | -250,000.00 |